FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway
- Resource Type
- Article
- Source
- In
Journal of Molecular and Cellular Cardiology February 2021 151:31-43 - Subject
- Language
- ISSN
- 0022-2828